Question:

Are blood derivatives such as albumin infused for therapeutic treatment of liver failure or diseases such as cirrhosis billed as a biological by the pharmacy?

Answer:

Yes, understand that blood derivatives such as albumin infused for therapeutic treatment of liver failure or diseases such as cirrhosis or nephrotic syndrome resulting in hypoalbuminemia are billed as a biological by the pharmacy, and the administration of that substance is reported as drug administration, not blood transfusion.

Facebook
Twitter
LinkedIn
Email
Print

CPT® copyright 2021 American Medical Association (AMA). All rights reserved.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

CPT is a registered trademark of the American Medical Association.